However, the specific mechanisms by which AIF1 inhibits tumor action by inhibiting the NF-kappa B signaling pathway, and whether AIF1 is beneficial as a future prevention and treatment target for osteosarcoma, remain to be further investigated. Here, AIF1 is linked to osteosarcoma.